There have been 50 recent insider transactions recorded for Aclaris Therapeutics, Inc. (ACRS), including 21 buys and 27 sells. Total insider buying was valued at RSU Award and total insider selling at $39.63K.
Notable insiders with recent activity include Balthaser Kevin, Walker Neal, Loerop James. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ACRS
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-01 |
Balthaser Kevin |
Chief Financial Officer |
Option Exercise (Sell) |
2,375 |
- |
- |
- |
| 2026-02-03 |
Walker Neal |
CEO |
Option Exercise (Sell) |
63,475 |
- |
- |
190,425 |
| 2026-02-03 |
Loerop James |
Chief Business Officer |
Option Exercise (Sell) |
20,875 |
- |
- |
62,625 |
| 2026-02-03 |
Balthaser Kevin |
Chief Financial Officer |
Option Exercise (Sell) |
22,025 |
- |
- |
66,075 |
| 2026-02-03 |
Davis Hugh M. |
President and COO |
Option Exercise |
18,675 |
- |
- |
45,425 |
| 2026-02-02 |
Walker Neal |
CEO |
RSU Award |
274,800 |
- |
- |
274,800 |
| 2026-02-02 |
Loerop James |
Chief Business Officer |
RSU Award |
97,700 |
- |
- |
97,700 |
| 2026-02-02 |
Balthaser Kevin |
Chief Financial Officer |
RSU Award |
99,100 |
- |
- |
99,100 |
| 2026-02-02 |
Davis Hugh M. |
President and COO |
RSU Award |
96,100 |
- |
- |
96,100 |
| 2026-02-02 |
Hall Jesse Wayne |
Chief Medical Officer |
RSU Award |
98,100 |
- |
- |
98,100 |
| 2026-02-02 |
Kolbeck Roland Wilhelm |
Chief Scientific Officer |
RSU Award |
95,700 |
- |
- |
95,700 |
| 2026-02-01 |
Balthaser Kevin |
Chief Financial Officer |
Option Exercise (Sell) |
14,750 |
- |
- |
29,500 |
| 2026-02-01 |
Loerop James |
Chief Business Officer |
Option Exercise (Sell) |
11,250 |
- |
- |
- |
| 2026-01-02 |
Walker Neal |
CEO |
Option Exercise (Sell) |
29,150 |
- |
- |
30,034 |
| 2026-01-02 |
Loerop James |
Chief Business Officer |
Option Exercise (Sell) |
18,150 |
- |
- |
18,700 |
| 2026-01-02 |
Balthaser Kevin |
Chief Financial Officer |
Option Exercise (Sell) |
13,200 |
- |
- |
13,600 |
| 2026-01-01 |
Balthaser Kevin |
Chief Financial Officer |
Option Exercise (Sell) |
7,500 |
- |
- |
7,500 |
| 2025-12-31 |
Loerop James |
Chief Business Officer |
Option Exercise (Sell) |
73,750 |
- |
- |
- |
| 2025-12-31 |
Balthaser Kevin |
Chief Financial Officer |
Option Exercise (Sell) |
73,750 |
- |
- |
- |
| 2025-12-02 |
Davis Hugh M. |
President and COO |
Option Exercise |
26,750 |
- |
- |
26,750 |
| 2025-08-01 |
Kolbeck Roland Wilhelm |
Chief Scientific Officer |
RSU Award |
145,500 |
- |
- |
145,500 |
| 2025-07-28 |
Kolbeck Roland Wilhelm |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-06-06 |
Schiff Andrew N |
Director |
Option Exercise (Sell) |
4,793 |
- |
- |
- |
| 2025-06-06 |
Milano Vincent |
Director |
Option Exercise (Sell) |
4,793 |
- |
- |
- |
| 2025-06-06 |
Gowen Maxine |
Director |
Option Exercise (Sell) |
4,793 |
- |
- |
- |
| 2025-06-06 |
Mehra Anand |
Director |
Option Exercise (Sell) |
4,793 |
- |
- |
- |
| 2025-06-06 |
Molineaux Christopher P. |
Director |
Option Exercise (Sell) |
4,793 |
- |
- |
- |
| 2025-06-06 |
Humphries William D. |
Director |
Option Exercise (Sell) |
4,793 |
- |
- |
- |
| 2025-06-05 |
Schiff Andrew N |
Director |
RSU Award |
11,580 |
- |
- |
11,580 |
| 2025-06-05 |
Milano Vincent |
Director |
RSU Award |
11,580 |
- |
- |
11,580 |
| 2025-06-05 |
Gowen Maxine |
Director |
RSU Award |
11,580 |
- |
- |
11,580 |
| 2025-06-05 |
Mehra Anand |
Director |
RSU Award |
11,580 |
- |
- |
11,580 |
| 2025-06-05 |
Molineaux Christopher P. |
Director |
RSU Award |
11,580 |
- |
- |
11,580 |
| 2025-06-05 |
Humphries William D. |
Director |
RSU Award |
11,580 |
- |
- |
11,580 |
| 2025-05-01 |
Walker Neal |
CEO |
Option Exercise (Sell) |
9,467 |
- |
- |
- |
| 2025-05-01 |
Hall Jesse Wayne |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-05-01 |
Hall Jesse Wayne |
Chief Medical Officer |
RSU Award |
145,500 |
- |
- |
145,500 |
| 2025-04-01 |
Walker Neal |
CEO |
Option Exercise (Sell) |
9,467 |
- |
- |
9,467 |
| 2025-03-01 |
Walker Neal |
CEO |
Option Exercise (Sell) |
9,466 |
- |
- |
18,934 |
| 2025-03-01 |
Monahan Joseph |
Chief Scientific Officer |
Option Exercise (Sell) |
50,000 |
- |
- |
- |
| 2025-03-01 |
Balthaser Kevin |
Chief Financial Officer |
Option Exercise (Sell) |
1,100 |
- |
- |
- |
| 2025-02-03 |
Walker Neal |
Interim CEO |
RSU Award |
253,900 |
- |
- |
253,900 |
| 2025-02-03 |
Loerop James |
Chief Business Officer |
RSU Award |
83,500 |
- |
- |
83,500 |
| 2025-02-03 |
Monahan Joseph |
Chief Scientific Officer |
RSU Award |
83,900 |
- |
- |
83,900 |
| 2025-02-03 |
Balthaser Kevin |
Chief Financial Officer |
RSU Award |
88,100 |
- |
- |
88,100 |
| 2025-02-03 |
Davis Hugh M. |
President and COO |
RSU Award |
74,700 |
- |
- |
74,700 |
| 2025-02-01 |
Loerop James |
Chief Business Officer |
Tax Withholding of RSU |
15,980 |
$2.48 |
$39.63K |
102,773 |
| 2025-02-01 |
Walker Neal |
Interim CEO |
Option Exercise (Sell) |
9,467 |
- |
- |
28,400 |
| 2025-02-01 |
Loerop James |
Chief Business Officer |
Option Exercise (Sell) |
11,250 |
- |
- |
11,250 |
| 2025-02-01 |
Monahan Joseph |
Chief Scientific Officer |
Option Exercise (Sell) |
7,500 |
- |
- |
15,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
